Autism Biotech Overview

  • Founded
  • 2012

Founded
  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Autism Biotech General Information

Description

Developer of a biochemical test designed to offer early diagnosis of autism. The company's test develops therapies and detects autism from a drop of blood, enabling doctors to treat medical needs of patients with a Autism.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • The Innovation Centre
  • Northern Ireland Science Park, Queen's Island
  • Belfas BT3 9DT
  • Northern Ireland, United Kingdom
+44 028 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Autism Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 31-Mar-2020 00000 Completed Out of Business
2. Early Stage VC 22-Dec-2014 00000 00000 00.00 Completed Startup
1. Grant Completed Startup
To view Autism Biotech’s complete valuation and funding history, request access »

Autism Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 00.000
To view Autism Biotech’s complete cap table history, request access »

Autism Biotech Patents

Autism Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2011341776-A1 Novel biomarker and uses thereof in diagnosis, treatment of autism Granted 16-Dec-2010 00000000000
CA-2821908-C Novel biomarker and uses thereof in diagnosis, treatment of autism Expired - Fee Related 16-Dec-2010 00000000000
AU-2011341776-B2 Novel biomarker and uses thereof in diagnosis, treatment of autism Ceased 16-Dec-2010 00000000000
JP-2014506244-A Biomarkers and their use in the diagnosis and treatment of autism Granted 16-Dec-2010 00000000000 0
JP-5960717-B2 Biomarkers and their use in the diagnosis and treatment of autism Expired - Fee Related 16-Dec-2010 G01N33/6896
To view Autism Biotech’s complete patent history, request access »